Vol. 6 No. 2 (2026): Special Issue: AI-Driven Drug Discovery and Testing Innovations: Bridging Computational Power and Clinical Translation
Special Issue Title
AI-Driven Drug Discovery and Testing Innovations: Bridging Computational Power and Clinical Translation
Aims & Scope
This special issue will highlight the transformative role of artificial intelligence in accelerating and reshaping the drug discovery pipeline. We welcome contributions that explore theoretical frameworks, computational methods, experimental validations, and translational applications
Topic of Interests (but not limited to)-
- Drug Discovery
- Preclinical Testing
- Data-Driven Approaches
- Translational Applications
- Regulatory, Ethical, and Industrial Perspectives
Types of Manuscripts Accepted
- Original Research
- Review Articles
- Mini Reviews
- Perspectives / Commentaries
- Systematic Reviews / Meta-analyses
- Short Communications
Important Dates
Manuscript Submission Deadline: 31 March 2026
Submission Guidelines
Visit Manuscript preparation guidelines for details.
Click here to submit to Special Issue
Note: While submitting, please choose the appropriate Article Type and mention in the Cover Letter that your manuscript is for this Special Issue.
Article Processing charge- APC Waiver availabe. Visit here for details.
Edited by
Dr. Kusum Sharma, V Mags Global EduTech, New Delhi, India
Email: skusum1399@gmail.com
Dr. Sachchida Nand Rai, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
Email: sn.rai@bhu.ac.in
Keywords
- AI in Drug Discovery
- Machine Learning
- Deep Learning
- Computational Pharmacology
- Predictive Toxicology
- Precision Medicine
- Systems Biology
- Translational Pharmacology
- Bioinformatics

